reuters.com · 16 jun

-Vodafone CEO urges Europe to allow mobile phone groups to scale to drive investment

The chief executive of Vodafone urged ​European governments to speed up ‌regulatory changes to allow mobile phone groups to develop ​the scale to drive ​the investment needed to ⁠keep up with the ​United States and Asia.

proactiveinvestors.co.uk · 15 jun

Vodafone Group offers upside says broker

Deutsche Bank sees roughly 30% upside in Vodafone Group PLC (LSE:VOD), arguing the telecoms giant is moving past some of its biggest strategic flashpoints even as Germany continues to weigh on the investment case. The broker reiterated its Buy rating, while trimming its price target to 150p from 155p.

proactiveinvestors.co.uk · 10 jun

Vodafone explores Greece fibre tie-up

Vodafone Group PLC (LSE:VOD) is exploring a merger of its Greek fibre network with that of regional utility giant PPC Group in a move that would create one of the country's largest wholesale broadband infrastructure providers. Vodafone Greece and PPC have signed heads of terms for a proposed 50:50 joint venture that would combine their respective fibre-to-the-home networks and wholesale fibre businesses, with the two networks currently serving more than 1.6 million homes combined.

globenewswire.com · 9 jun

Digitalage Opens Commercial VOD Library Intake and Live Broadcasting Across News, Sports, Events, and Faith Programming

Digitalage expands verified media infrastructure into VOD and live broadcasting across news, sports, events, and faith programming. Content intake now open

proactiveinvestors.co.uk · 4 jun

Vodafone and Sainsbury's lead FTSE 100 fallers as shares trade ex-div

Vodafone Group PLC (LSE:VOD) and J Sainsbury PLC (LSE:SBRY) led the FTSE 100 fallers on Thursday after their shares went ex-dividend.  The index was hit by a 3.5-point drag from five companies' shares trading ex-div.

gurufocus.com · 28 may

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the

fool.com · 26 may

AST SpaceMobile vs. Rocket Lab: Which Space Stock Is a Better Buy in 2026?

These two ambitious players are reshaping the space economy, but their distinct business profiles and paths create very different risk and reward profiles for investors.

247wallst.com · 26 may

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More

Pre-Market Stock Futures: Futures are trading higher as investors return to a holiday-shortened trading week after a record-setting Friday, when the S&P 500, which posted its eighth straight weekly gain, and the Dow Jones Industrial Average both posted new all-time highs, closing at 7,473 and 50,579, respectively. Not to be left behind, the Nasdaq closed... Here Are Tuesday's Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More